Michael John Rance
Direttore/Membro del Consiglio presso MNLpharma Ltd.
Posizioni attive di Michael John Rance
Società | Posizione | Inizio | Fine |
---|---|---|---|
MNLpharma Ltd.
MNLpharma Ltd. Pharmaceuticals: MajorHealth Technology MNLpharma Ltd. develops and sells pharmaceuticals. It offers therapeutic products, research equipment, and related services. The company developed a molecule Immunomodulators for the treatment of cancer, infectious diseases, and immune disorders. It was founded in 1999 and is headquartered in Aberystwyth, UK | Direttore/Membro del Consiglio | 21/02/2005 | - |
Storia della carriera di Michael John Rance
Precedenti posizioni note di Michael John Rance
Società | Posizione | Inizio | Fine |
---|---|---|---|
Medical Marketing International Group Plc
Medical Marketing International Group Plc Medical/Nursing ServicesHealth Services Medical Marketing International Group Plc is a life sciences company that identifies and acquires from academic organisations, technologies that have potential to satisfy unmet needs in major markets, such as cancer and infectious disease. It also offers a range of technical support services to United Kingdom academic and commercial bodies. The Group's operation focuses on the areas of vaccines, chemotherapy and Ribozyme anti-virals. Vaccines relates to diseases such as lymphoma, prostate cancer, CEA cancer, myeloma, CMV, influenza and tubercolosis. Chemotherapy research relates to ruthenium and pineapple protease. The company was founded in 1988 and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | - | 19/09/2007 |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | - | - |
Reckitt & Colman Plc | Corporate Officer/Principal | - | - |
ASTRAZENECA PLC | Public Communications Contact | 25/03/2002 | - |
Statistiche
Distribuzione geografica
Regno Unito | 5 |
Stati Uniti | 2 |
Posizioni
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Public Communications Contact | 1 |
Settori
Health Technology | 4 |
Health Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ASTRAZENECA PLC | Health Technology |
Aziende private | 4 |
---|---|
Medical Marketing International Group Plc
Medical Marketing International Group Plc Medical/Nursing ServicesHealth Services Medical Marketing International Group Plc is a life sciences company that identifies and acquires from academic organisations, technologies that have potential to satisfy unmet needs in major markets, such as cancer and infectious disease. It also offers a range of technical support services to United Kingdom academic and commercial bodies. The Group's operation focuses on the areas of vaccines, chemotherapy and Ribozyme anti-virals. Vaccines relates to diseases such as lymphoma, prostate cancer, CEA cancer, myeloma, CMV, influenza and tubercolosis. Chemotherapy research relates to ruthenium and pineapple protease. The company was founded in 1988 and is headquartered in Cambridge, the United Kingdom. | Health Services |
MNLpharma Ltd.
MNLpharma Ltd. Pharmaceuticals: MajorHealth Technology MNLpharma Ltd. develops and sells pharmaceuticals. It offers therapeutic products, research equipment, and related services. The company developed a molecule Immunomodulators for the treatment of cancer, infectious diseases, and immune disorders. It was founded in 1999 and is headquartered in Aberystwyth, UK | Health Technology |
Reckitt & Colman Plc | Commercial Services |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
- Borsa valori
- Insiders
- Michael John Rance
- Esperienza